|
|
Select HistoricalFinancials Updated to reflect treatment of Pigments & Additives as discontinued operations |
|
|
General As previously announced, we completed the separation of our Pigments & Additives division through an Initial Public Offering (“IPO”) of ordinary shares of Venator Materials PLC (“Venator”) on August 8, 2017. It is our intention to monetize our 75.4% retained ownership in Venator at prevailing market conditions and expect to implement multiple follow-on capital market or block transactions that permit an orderly distribution of Huntsman's retained shares. This presentation reclassifies select historical financial data, reflecting the results of the associated Pigments & Additives business as discontinued operations. This presentation contains financial measures that are not in accordance with generally accepted accounting principles in the U.S. ("GAAP"), including EBITDA, adjusted EBITDA, adjusted EBITDA from discontinued operations, normalized EBITDA, adjusted net income (loss), adjusted diluted income (loss) per share, free cash flow and net debt. The Company has provided reconciliations of non-GAAP financial measures to the most directly comparable GAAP financial measures in the Appendix to this presentation. Forward-Looking Statements: This presentation includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements include statements concerning our plans, objectives, goals, strategies, future events, future revenue or performance, capital expenditures, financing needs, plans or intentions relating to acquisitions, business trends and other information that is not historical information. When used in this presentation, the words “estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes,” “forecasts,” or future or conditional verbs, such as “will,” “should,” “could” or “may,” and variations of such words or similar expressions are intended to identify forward-looking statements. All forward-looking statements, including, without limitation, management’s examination of historical operating trends and data, are based upon our current expectations and various assumptions. Our expectations, beliefs and projections are expressed in good faith, and we believe there is a reasonable basis for them. However, there can be no assurance that management’s expectations, beliefs and projections will be achieved. We assume no obligation to provide revisions to any forward-looking statements should circumstances change, except as required by applicable laws. The forward-looking statements in this release are subject to uncertainty and changes in circumstances and involve risks and uncertainties that may affect the company's operations, markets, products, services, prices and other factors as discussed in the Huntsman companies' filings with the U.S. Securities and Exchange Commission. Significant risks and uncertainties may relate to, but are not limited to, volatile global economic conditions, cyclical and volatile product markets, disruptions in production at manufacturing facilities, reorganization or restructuring of Huntsman’s operations, including any delay of, or other negative developments affecting, the separation of Venator Materials PLC, the ability to implement cost reductions and manufacturing optimization improvements in Huntsman businesses and realize anticipated cost savings, and other financial, economic, competitive, environmental, political, legal, regulatory and technological factors. All forward-looking statements attributable to us or persons acting on our behalf apply only as of the date made and are expressly qualified in their entirety by the cautionary statements included in this presentation. We undertake no obligation to update or revise forward-looking statements which may be made to reflect events or circumstances that arise after the date made or to reflect the occurrence of unanticipated events. 2 |
|
|
2017 |
|
|
2017 Results of Operations 2017 Six months ended Jun 30 Three months ended Mar 31 Jun 30 In millions, except per share amounts Revenues Cost of goods sold Gross profit Operating expenses Restructuring, impairment and plant closing costs $ 1,932 1,540 $ 2,054 1,617 $ 3,986 3,157 392 219 9 - 437 220 3 6 829 439 12 Expenses associated with the merger Operating income Interest expense Equity in income of investment in unconsolidated affiliates Loss on early extinguishment of debt 164 (48) - - 208 (47) 3 (1) 372 (95) 3 (1) Other income (expense) 2 (1) 1 Income before income taxes Income tax expense Income from continuing operations (Loss) income from discontinued operations, net of tax(4) Net income Net income attributable to noncontrolling interests, net of tax Net income attributable to Huntsman Corporation 118 (19) 162 (24) 280 (43) 99 (7) 138 45 237 38 92 (16) 183 (16) 275 (32) $ 76 $ 167 $ 243 Adjusted EBITDA(1) Adjusted net income(1) Basic income per share Diluted income per share Adjusted diluted income per share(1) $ $ 260 110 $ $ 299 144 $ $ 559 254 $ $ $ 0.32 0.31 0.45 $ $ $ 0.70 0.69 0.59 $ $ $ 1.02 1.00 1.04 Common share information: Basic shares outstanding Diluted shares Diluted shares for adjusted diluted income per share See appendix of presentation for footnote explanations 237 243 238 244 238 243 243 243 244 4 6 |
|
|
2017 Reconciliation of US GAAP Quarterly to Non-GAAP Measures 2017 Income Tax Expense Diluted Income Per Share EBITDA Net Income Three months ended Three months ended Three months ended Three months ended In millions, except per share amounts Mar 31 Jun 30 Mar 31 Jun 30 Mar 31 Jun 30 Mar 31 Jun 30 Net income Net income attributable to noncontrolling interests Net income attributable to Huntsman Corporation Interest expense from continuing operations Income tax expense from continuing operations Income tax (benefit) expense from discontinued operations(4) Depreciation and amortization from continuing operations Depreciation and amortization from discontinued operations(4) Acquisition and integration expenses EBITDA / Loss (income) from discontinued operations, net of tax(4) Minority interest of discontinued operations $ 92 $183 (16) $ 92 $183 (16) $ 0.38 (0.07) $ 0.75 (0.07) (16) (16) 76 48 19 3 76 30 3 (26) 3 167 47 24 21 79 29 4 (95) 3 76 167 $ (19) $ (24) (1) N/A N/A - N/A N/A 2 7 3 4 (45) 3 0.01 0.03 0.01 0.02 (0.18) 0.01 Gain on disposition of businesses/assets Loss on early extinguishment of debt - - (8) 1 - - - - - - (8) 1 - - (0.03) - Expenses associated with merger, net of tax Certain legal settlements and related expenses Amortization of pension and postretirement actuarial losses Restructuring, impairment and plant closing and transition costs Adjusted(1) - - 6 1 17 3 - - - - 6 1 13 2 - - 0.06 0.03 0.02 - 0.05 0.01 - - 19 9 (4) (2) (4) (1) 15 7 $ 260 $ 299 $ (26) $ (29) $ 110 $ 144 Adjusted income tax expense(1) Net income attributable to noncontrolling interests, net of tax Minority interest of discontinued operations Adjusted pre-tax income(1) Adjusted effective tax rate $ 26 16 (3) $ 29 16 (3) $ 149 $ 186 17% 16% 5 $ 0.59 $ 0.45 0.69 0.31 |
|
|
2017 Reconciliation of US GAAP to Non-GAAP Measures June YTD Six months ended Jun 30, 2017 Income Tax Expense Diluted Income Per Share In millions, except per share amounts EBITDA Net Income $ 275 (32) $ 275 (32) $ 1.13 (0.13) Net income Net income attributable to noncontrolling interests Net income attributable to Huntsman Corporation Interest expense from continuing operations Income tax expense from continuing operations Income tax expense from discontinued operations(4) Depreciation and amortization from continuing operations Depreciation and amortization from discontinued operations(4) Acquisition and integration expenses EBITDA / Income from discontinued operations, net of tax(4) Minority interest of discontinued operations 243 95 43 24 155 59 7 (121) 6 243 $ (43) (1) N/A N/A 6 (38) 6 0.02 (0.16) 0.02 Gain on disposition of businesses/assets Loss on early extinguishment of debt (8) 1 - - (8) 1 (0.03) - Expenses associated with merger, net of tax Certain legal settlements and related expenses Amortization of pension and postretirement actuarial losses Restructuring, impairment and plant closing and transition costs Adjusted(1) 6 1 36 12 - 6 1 28 9 0.02 - 0.12 0.04 - (8) (3) $ 559 $ (55) $ 254 Adjusted income tax expense(1) Net income attributable to noncontrolling interests, net of tax Minority interest of discontinued operations Adjusted pre-tax income(1) Adjusted effective tax rate $ 55 32 (6) $ 335 16% 6 $ 1.04 1.00 |
|
|
2017 Selected Balance Sheet Items 2017 Mar 31 Jun 30 In millions Cash Accounts and notes receivable, net Inventories Other current assets Current assets held for sale Property, plant and equipment, net Other assets Noncurrent assets held for sale Total assets $ 434 1,249 1,057 301 794 3,030 1,176 1,447 $ 486 1,207 1,089 236 962 3,039 1,194 1,475 $ 9,488 $ 9,688 Accounts payable Other current liabilities Current portion of debt Current liabilities held for sale Long-term debt Other liabilities $ 864 452 51 488 4,148 1,448 $ 864 460 41 518 4,061 1,466 Noncurrent liabilities held for sale 388 400 Total equity Total liabilities and equity 1,649 1,878 $ 9,488 $ 9,688 7 |
|
|
8 HUNTSMAN 2017 Summarized Statement of Cash Flows 2017 Six months Three months ended ended In millions Mar 31 Jun 30 Jun 30 Total cash at beginning of period<al$425 $469 $ 425 Net cash provided by operating activities-continuing operations 70 207 277 Net cash provided by operating activities-discontinued operations(4)23 94 117 Net cash used in investing activities-continuing operations (48) (47) (95) Net cash provided by (used in) investing activities-discontinued operations(4) 24 (12) 12 Net cash used in financing activities (31) (193) (224) Effect of exchange rate changes on cash 5 3 8 Change in restricted cash 1 (1) Total cash at end of period(a) $469 $520 $ 520 Supplemental cash flow information - continuing operations: Cash paid for interest $(36) $(56) $ (92) Cash (paid) received for income taxes (8) 65 57 Cash paid for capital expenditures (51) (50) (101) Depreciation and amortization 76 79 155 Changes in primary \I\Orking capital: Accounts and notes receivable $ (55) $ (65) $ (120) Inventories (109) (28) (137) Accounts payable 83 (4) 79 Total cash used in primary \I\Orking capital $(81) $(97) $ (178) |
|
|
2017 Free Cash Flow 2017 Six months ended Jun 30 Three months ended In millions Mar 31 Jun 30 Free cash flow(3): Net cash provided by operating activities Capital expenditures All other investing activities, excluding acquisition and disposition activities(b) $ 70 (51) $ 207 (50) $ 277 (101) 3 (2) 1 Total free cash flow(3) $ 22 $ 155 $ 177 Adjusted EBITDA Capital expenditures Capital reimbursements Interest Income taxes Primary working capital change Restructuring Pensions $ 260 (51) 1 (36) (8) (81) (9) (15) $ 299 (50) - (56) 65 (97) (10) (22) $ 559 (101) 1 (92) 57 (178) (19) (37) Maintenance & other Total free cash flow(3) (39) 26 (13) $ 22 $ 155 $ 177 Free cash flow of discontinued operations (3)(4) $ 60 $ 96 $ 156 (a) Includes restricted cash. (b) Represents "Acquisition of business, net of cash acquired", "Cash received from purchase price adjustment for business acquired", and "Proceeds from sale of business/assets". 9 |
|
|
2016 |
|
|
2016 Results of Operations 2016 Twelve months ended Dec 31 Three months ended Mar 31 Jun 30 Sept 30 Dec 31 In millions, except per share amounts $ 1,815 1,425 $ 1,968 1,544 $ 1,831 1,475 $ 1,904 1,548 $ 7,518 5,992 Revenues Cost of goods sold Gross profit Operating expenses Restructuring, impairment and plant closing costs (credits) Operating income Interest expense Equity in income of investment in unconsolidated affiliates Loss on early extinguishment of debt 390 223 2 424 224 16 356 217 38 356 140 (9) 1,526 804 47 165 (49) 1 - 184 (52) 2 (2) 101 (52) 1 (1) 225 (50) 1 - 675 (203) 5 (3) Other income (expense) 1 1 (3) 1 - Income before income taxes Income tax expense Income from continuing operations (Loss) income from discontinued operations, net of tax(4) Net income Net income attributable to noncontrolling interests, net of tax Net income attributable to Huntsman Corporation 118 (33) 133 (26) 46 (6) 177 (44) 474 (109) 85 (23) 107 (13) 40 24 133 4 365 (8) 62 (6) 94 (7) 64 (9) 137 (9) 357 (31) $ 56 $ 87 $ 55 $ 128 $ 326 Adjusted EBITDA(1) Adjusted net income(1) Basic income per share Diluted income per share Adjusted diluted income per share(1) $ $ 259 95 $ $ 294 133 $ $ 234 74 $ $ 210 50 $ $ 997 352 $ $ $ 0.24 0.24 0.40 $ $ $ 0.37 0.36 0.56 $ $ $ 0.23 0.23 0.31 $ $ $ 0.54 0.53 0.21 $ $ $ 1.38 1.36 1.47 Common share information: Basic shares outstanding Diluted shares Diluted shares for adjusted diluted income per share See appendix of presentation for footnote explanations 236 238 236 240 236 240 236 241 236 240 240 238 240 240 241 11 |
|
|
2016 Reconciliation of US GAAP to Non-GAAP Measures Quarterly 2016 Income Tax Expense Diluted Income Per Share EBITDA Net Income Three months ended Three months ended Three months ended Three months ended Mar 31 Jun 30 Sept 30 Dec 31 Mar 31 Jun 30 Sept 30 Dec 31 Mar 31 Jun 30 Sept 30 Dec 31 Mar 31 Jun 30 Sept 30 Dec 31 In millions, except per share amounts $ 62 (6) $ 94 (7) $ 64 (9) $ 137 (9) $ 62 (6) $ 94 (7) $ 64 (9) $ 137 (9) $ 0.26 (0.03) $ 0.39 (0.03) $ 0.27 (0.04) $ 0.57 (0.04) Net income Net income attributable to noncontrolling interests Net income attributable to Huntsman Corporation Interest expense from continuing operations Interest expense (income) from discontinued operations(4) Income tax expense from continuing operations Income tax (benefit) expense from discontinued operations(4) Depreciation and amortization from continuing operations Depreciation and amortization from discontinued operations(4) Acquisition and integration expenses EBITDA / Loss (income) from discontinued operations, net of tax(4) Minority interest of discontinued operations 56 49 1 33 (7) 77 23 3 6 2 87 52 (2) 26 6 78 31 2 (22) 3 55 52 128 50 - 44 (16) 80 30 1 (18) 3 56 87 55 128 - 6 (7) 83 30 6 (47) 3 $ (33) $ (26) $ (6) $ (44) (1) N/A N/A - N/A N/A (2) N/A N/A - N/A N/A 2 23 2 2 13 3 4 (24) 3 1 (4) 3 0.01 0.10 0.01 0.01 0.05 0.01 0.02 (0.10) 0.01 - (0.02) 0.01 Gain on disposition of businesses/assets Loss on early extinguishment of debt - - - - (97) - - - - - - 13 - - - - (84) - - - - - - - (0.35) - 2 1 (1) - 1 1 Certain legal settlements and related expenses Amortization of pension and postretirement actuarial losses Restructuring, impairment and plant closing and transition costs (credits) Adjusted(1) - - - 1 13 (9) - - - - - - - 1 11 (6) - 0.05 - - 0.05 0.06 - 0.04 0.11 - 0.05 (0.02) 14 2 14 17 14 38 (3) (1) (2) (2) (5) (12) (2) 3 11 1 12 15 9 26 $ 259 $ 294 $ 234 $ 210 $ (38) $ (31) $ (25) $ (30) $ 95 $ 133 $ 74 $ 50 Pro forma adjustments(2) (7) (8) (7) (6) Pro forma adjusted EBITDA(1) $ 252 $ 286 $ 227 $ 204 Adjusted income tax expense(1) Net income attributable to noncontrolling interests, net of tax Minority interest of discontinued operations Adjusted pre-tax income(1) Adjusted effective tax rate $ 38 6 (2) $ 31 7 (3) $ 25 9 (3) $ 30 9 (3) $ 137 $ 168 $ 105 $ 86 28% 18% 24% 35% 12 $ 0.21 $ 0.31 $ 0.56 $ 0.40 0.53 0.23 0.36 0.24 |
|
|
2016 Reconciliation of US GAAP to Non-GAAP Measures Full Year Twelve months ended Dec 31, 2016 Income Tax Expense Diluted Income Per Share EBITDA Net Income In millions, except per share amounts Net income Net income attributable to noncontrolling interests Net income attributable to Huntsman Corporation Interest expense from continuing operations Interest income from discontinued operations(4) Income tax expense from continuing operations Income tax benefit from discontinued operations(4) Depreciation and amortization from continuing operations Depreciation and amortization from discontinued operations(4) Acquisition and integration expenses EBITDA / Income from discontinued operations, net of tax(4) Minority interest of discontinued operations $ 357 (31) $ 357 (31) $ 1.49 (0.13) 326 203 (1) 109 (24) 318 114 12 (81) 11 326 $ (109) (3) N/A N/A 9 8 11 0.04 0.03 0.05 Gain on disposition of businesses/assets Loss on early extinguishment of debt (97) 3 13 (1) (84) 2 (0.35) 0.01 Certain legal settlements and related expenses Amortization of pension and postretirement actuarial losses Restructuring, impairment and plant closing and transition costs Adjusted(1) 1 55 48 - (12) (12) 1 43 36 - 0.18 0.15 $ 997 $ (124) $ 352 Pro forma adjustments(2) (28) Pro forma adjusted EBITDA(1) $ 969 Adjusted income tax expense(1) Net income attributable to noncontrolling interests, net of tax Minority interest of discontinued operations Adjusted pre-tax income(1) Adjusted effective tax rate $ 124 31 (11) $ 496 25% 13 $ 1.47 1.36 |
|
|
2016 Selected Balance Sheet Items 2016 In millions Mar 31 Jun 30 Sept 30 Dec 31 Cash Accounts and notes receivable, net Inventories Other current assets Current assets held for sale Property, plant and equipment, net Other assets Noncurrent assets held for sale Total assets $ 192 1,270 1,156 277 935 3,149 1,273 $ 359 1,277 1,068 271 816 3,124 1,268 $ 432 1,210 1,000 317 824 3,051 1,227 1,646 $ 396 1,183 918 281 777 3,034 1,137 1,463 1,588 1,544 $ 9,840 $ 9,727 $ 9,707 $ 9,189 Accounts payable Other current liabilities Current portion of debt Current liabilities held for sale Long-term debt Other liabilities $ 722 451 93 516 4,707 1,316 $ 717 420 86 466 4,637 1,355 $ 719 486 78 506 4,453 1,348 $ 790 471 50 467 4,122 1,429 Noncurrent liabilities held for sale 350 338 346 393 Total equity Total liabilities and equity 1,685 1,708 1,771 1,467 $ 9,840 $ 9,727 $ 9,707 $ 9,189 14 |
|
|
> > 15 HUNTSMAN 2016 Summarized Statement of Cash Flows 2016 Twelve months Three months ended ended In millions Mar31Jun 30 Sept30Dec31Dec31 Totalcash at begilnilg of period(a)$ 269$ 218 $ 383$450 $269 Net cash provided by operating activities - continuing operations 126 277 333 238 974 Net cash provided by (used in) operating activities-discontinued operations<4 (38) 78 72 2 114 Net cash (used in) provided by in sting activities-continuing operations (68) (63) (82) 94 (119) Net cash used in in sting activities-discontinued operations<4 (33) (10) (14) (26) (83) Net cash used in financing activities (38) (115) (244) (326) (723) Effect of exchange rate changes on cash 2 (2) 1 (7) (6) Change in restricted cash (2) 1 (1) Totalcash at end of period(a)$ 218 $ 383 $ 450 $425 $425 Supplementalcash flow information - continuing operations: Cash paid for interest $ (35) $ (68) $ (36) $ (66) $ (205) Cash paid for incorre taxes (5) (16) (8) (11) (40) Cash paid for capitalexpenditures (67) (65) (82) (104) (318) Depreciation and amortization 77 78 83 80 318 Changes in primary working capita:l Accounts and notes receivable $ (54) $ (17) $ 68 $(22) $(25) ln ntories(7) 83 57 44 177 Accounts payable (22) (2) 13 57 46 Totalcash (used in) provided by primary working capital $ (83) $ 64 $ 138 $ 79 $ 198 |
|
|
2016 Free Cash Flow 2016 Twelve months ended Dec 31 Three months ended Mar 31 Jun 30 Sept 30 Dec 31 In millions Free cash flow(3): Net cash provided by operating activities Capital expenditures All other investing activities, excluding acquisition and disposition activities(b) Total free cash flow(3) $ 126 (67) $ 277 (65) $ 333 (82) $ 238 (104) $ 974 (318) (1) 2 - (1) - $ 58 $ 214 $ 251 $ 133 $ 656 Adjusted EBITDA Capital expenditures $ 259 (67) $ 294 $ 234 $ 210 $ 997 (65) 26 (68) (16) 64 (19) (16) 14 (82) 2 (36) (8) 138 (19) (13) 35 (104) 4 (66) (11) 79 (4) (15) 40 (318) 32 (205) (40) 198 (46) (60) 98 Capital reimbursements - Interest Income taxes Primary working capital change Restructuring Pensions Maintenance & other Total free cash flow(3) (35) (5) (83) (4) (16) 9 $ 58 $ 214 $ 251 $ 133 $ 656 Free cash flow of discontinued operations (3)(4) $ (71) $ 68 $ 52 $ (19) $ 30 (a) Includes restricted cash. (b) Represents "Acquisition of business, net of cash acquired", "Cash received from purchase price adjustment for business acquired", and "Proceeds from sale of business/assets". 16 |
|
|
Appendix |
|
|
Adjusted EBITDA Reconciliation 3Q15 4Q15 1Q16 2Q16 3Q16 4Q16 1Q17 2Q17 3Q17 ($ in millions) Net Income Net income attributable to noncontrolling interests Net income (loss) attributable to Huntsman Corporation Interest expense, net Income tax expense (benefit) Depreciation and amortization Interest, income taxes, depreciation and amortization in discontinued operations $ 63 $ 9 (5) $ 62 (6) $ 94$ 64 $ 137 (9) $ 92$ 183 $ 179 (32) (8) (7) (9) (16) (16) $ 55 49 $ 4 47 $ 56 49 33 77 17 3 6 2 $ 87 52 26 78 35 2 (22) 3 - 2 - $ 55 52 6 83 23 6 (47) 3 - 1 - $ 128 50 44 80 14 1 (18) 3 (97) - 1 $ 76 $ 167 47 24 79 50 4 (95) 3 (8) 1 1 $ 147 39 35 80 34 10 (97) 12 - 35 - 48 19 76 33 3 (26) 3 - - - 37 75 39 (46) 75 31 Acquisition and integration expenses, purchase accounting adjustments 1 15 2 - 8 - 3 67 2 1 EBITDA from discontinued operations Minority interest of discontinued operations Loss (gain) on disposition of businesses/assets Loss on early extinguishment of debt Certain legal settlements and related expenses - - - - 1 Plant incident remediation costs - - - - - - - - 13 Expenses associated with merger Amortization of pension and postretirement actuarial losses Restructuring, impairment, plant closing and transition costs (credits) Adjusted EBITDA Sale of European differentiated surfactants business(2) Proforma adjusted EBITDA - 16 9 - - - 14 - 14 - 13 (9) - 6 17 3 12 19 1 16 39 14 2 19 9 17 38 306 240 259 294 234 210 260 299 340 (5) (4) (7) (8) (7) (6) - - - $ 301 $ 236 $ 252 $ 286 $ 227 $ 204 $ 260 $ 299 $ 340 2010 2011 2012 2013 2014 2015 2016 3Q17 LTM Net Income Net income attributable to noncontrolling interests Net income attributable to Huntsman Corporation Interest expense, net Income tax (benefit) expense Depreciation and amortization Interest, income taxes, depreciation and amortization in discontinued operations Acquisition and integration expenses, purchase accounting adjustments (Gain) loss on initial consolidation of subsidiaries EBITDA from discontinued operations Minority interest of discontinued operations (Gain) loss on disposition of businesses/assets Loss on early extinguishment of debt Extraordinary (gain) loss on the acquisition of a business Certain legal settlements and related expenses $ 32 $254$ 373$ 149$ 345 $ 126$ 357$ 591 (5) (7) (10) (21) (22) (33) (31) (73) $ 27 229 $ 247 249 $ 363 226 $ 128 190 $ 323 205 $ 93 205 $ 326 203 109 318 89 12 - $ 518 184 122 315 131 18 - (2) 329 117 39 356 148 104 350 144 109 364 98 59 358 77 60 298 85 2 - (260) (1) - 183 1 8 - - 4 2 (12) (498) - (34) 7 (4) 46 - - - 5 4 (350) - - 80 (2) 2 - - - 33 105 11 - (78) - - 51 - 4 - 1 - 64 160 7 - 63 1 (2) 28 - - - 2 - 41 102 9 - 217 7 1 31 - 1 - - - 66 87 (81) (236) 11 21 (97) 3 (105) 36 - 1 - - - 55 48 - 2 13 - 18 68 4 Plant incident remediation costs (1) Pro forma adjusted to include the Polyurethanes system house acquired from Rockwood in October 2014. (2) Pro forma adjusted for the sale of the European Surfactants business on December 30, 2016. Purchase accounting inventory adjustments Expenses associated with merger Amortization of pension and postretirement actuarial losses Restructuring, impairment, plant closing and transition costs Adjusted EBITDA Acquisition of PU Systems house from Rockwood(1) Sale of European differentiated surfactants business(2) 20 25 21 157 678 728 1,064 1,102 1,264 1,160 997 1,109 4 (18) 5 (16) 5 (13) 6 (10) 7 (8) - (21) - (28) - (6) Proforma adjusted EBITDA $ 664 $ 717 $ 1,056 $ 1,098 $ 1,263 $ 1,139 $ 969 $ 1,103 18 |
|
|
Revenue, Adjusted EBITDA & Margin by Segment ($ in millions) Revenue Polyurethanes Performance Products Advanced Materials Textile Effects Corporate, LIFO and other Total Pro Forma(2)(3) Pro Forma(2)(3) Pro Forma(2)(3) Pro Forma(2)(3) Pro Forma(2)(3) Pro Forma(2)(3) Pro Forma(2) Pro Forma(2) 3Q15 4Q15 1Q16 2Q16 3Q16 4Q16 1Q17 2Q17 3Q17 $ 1,017 555 275 196 $ 909 491 256 186 $ 836 475 266 185 $ 976 507 261 198 $ 891 451 247 184 $ 964 452 246 184 $ 953 533 259 188 $ 1,022 561 260 205 $ 1,197 501 263 193 (11) (24) (8) (33) - (5) (1) 6 15 $ 2,032 $ 1,818 $ 1,754 $ 1,909 $ 1,773 $ 1,841 $ 1,932 $ 2,054 $ 2,169 Pro Forma(2) Pro Forma(2) Pro Forma(2)(3) Pro Forma(2)(3) Pro Forma(2)(3) Pro Forma(2)(3) Pro Forma(2)(3) Pro Forma(2)(3) Revenue Polyurethanes Performance Products Advanced Materials Textile Effects Corporate, LIFO and other Total 2010 2011 2012 2013 2014 2015 2016 3Q17 LTM $ 3,625 2,160 1,244 787 $ 4,456 2,679 1,372 737 $ 4,915 2,574 1,325 752 $ 4,991 2,566 1,267 811 $ 5,053 2,695 1,248 896 $ 3,811 2,251 1,103 804 $ 3,667 1,885 1,020 751 $ 4,136 2,047 1,028 770 (258) (265) (285) (251) (219) (80) (46) 15 $ 7,558 $ 8,979 $ 9,281 $ 9,384 $ 9,673 $ 7,889 $ 7,277 $ 7,996 ($ in millions) Adjusted EBITDA(1) Polyurethanes Performance Products Advanced Materials Textile Effects Corporate, LIFO and other Total Pro Forma(2)(3) Pro Forma(2)(3) Pro Forma(2)(3) Pro Forma(2)(3) Pro Forma(2)(3) Pro Forma(2)(3) Pro Forma(2) Pro Forma(2) 3Q15 4Q15 1Q16 2Q16 3Q16 4Q16 1Q17 2Q17 3Q17 $ 168 117 56 10 $ 141 72 48 13 $ 131 85 60 18 $ 171 78 58 24 $ 137 63 55 17 $ 130 62 50 14 $ 144 84 54 21 $ 167 102 56 24 $ 245 63 56 19 (50) (38) (42) (45) (45) (52) (43) (50) (43) $ 301$ 236$ 252$ 286$ 227$ 204$ 260$ 299$ 340 Pro Forma(2) Pro Forma(2) Pro Forma(2)(3) Pro Forma(2)(3) Pro Forma(2)(3) Pro Forma(2)(3) Pro Forma(2)(3) Pro Forma(2)(3) Adjusted EBITDA(1) Polyurethanes 2010 2011 2012 2013 2014 2015 2016 3Q17 LTM $ 337 371 (18) 353 144 16 $ 495 381 (16) 365 114 (64) $ 793 369 (13) 356 98 (20) $ 746 403 (10) 393 131 16 $ 729 473 (8) 465 199 58 $ 573 460 (21) 439 220 63 $ 569 316 (28) 288 223 73 $ 686 317 (6) 311 216 78 Performance Products - as re European Differentiated Surfa Performance Products Advanced Materials Textile Effects Corporate, LIFO and other Total (186) (193) (171) (188) (188) (156) (184) (188) $ 664 $ 717 $ 1,056 $ 1,098 $ 1,263 $ 1,139 $ 969 $ 1,103 Pro Forma(2)(3) Pro Forma(2)(3) Pro Forma(2)(3) Pro Forma(2)(3) Pro Forma(2)(3) Pro Forma(2)(3) Pro Forma(2) Pro Forma(2) Adj. EBITDA Margin Polyurethanes Performance Products Advanced Materials Textile Effects Total 3Q15 4Q15 1Q16 2Q16 3Q16 4Q16 1Q17 2Q17 3Q17 17% 21% 20% 16% 15% 19% 16% 18% 23% 18% 15% 22% 15% 14% 22% 13% 14% 20% 15% 16% 21% 16% 18% 22% 20% 13% 21% 5% 7% 10% 12% 9% 8% 11% 12% 10% 15% 13% 14% 15% 13% 11% 13% 15% 16% (1) For a reconciliation see Pro Forma(2) Pro Forma(2) Pro Forma(2)(3) Pro Forma(2)(3) Pro Forma(2)(3) Pro Forma(2)(3) Pro Forma(2)(3) Pro Forma(2)(3) previous page. Adj. EBITDA Margin Polyurethanes Performance Products Advanced Materials Textile Effects Total 2010 2011 2012 2013 2014 2015 2016 3Q17 LTM (2) Pro forma adjusted to exclude the Pigments & Additives business (Venator), which is held for sale as of the IPO in August 2017. (3) Pro forma adjusted for the sale of the European Surfactants business on December 30, 2016. 9% 16% 12% 11% 14% 8% 16% 14% 7% 15% 15% 10% 14% 17% 16% 15% 20% 20% 16% 15% 22% 17% 15% 21% 2% -9% -3% 2% 6% 8% 10% 10% 9% 8% 11% 12% 13% 14% 13% 14% 19 |
|
|
Explanatory Notes We use adjusted EBITDA to measure the operating performance of our business and for planning and evaluating the performance of our business segments. We provide adjusted net income because we feel it provides meaningful insight for the investment community into the performance of our business. We believe that net income (loss) is the performance measure calculated and presented in accordance with generally accepted accounting principles in the U.S. (“GAAP”) that is most directly comparable to adjusted EBITDA and adjusted net income. Additional information with respect to our use of each of these financial measures follows: Adjusted EBITDA, adjusted net income (loss) and adjusted diluted income (loss) per share, as used herein, are not necessarily comparable to other similarly titled measures of other companies. Adjusted EBITDA is computed by eliminating the following from net income (loss): (a) net income attributable to noncontrolling interests, net of tax; (b) interest; (c) income taxes; (d) depreciation and amortization; (e) acquisition and integration expenses; (f) EBITDA from discontinued operations; (g) minority interest from discontinued operations; (h) loss (gain) on disposition of businesses/assets; (i) loss on early extinguishment of debt; (j) expenses associated with merger, net of tax; (k) certain legal settlements and related expenses; (l) amortization of pension and postretirement actuarial losses (gains) and; (m) restructuring, impairment and plant closing and transition costs (credits). The reconciliation of adjusted EBITDA to net income (loss) is set forth in these tables. Adjusted net income (loss) and adjusted diluted income (loss) per share are computed by eliminating the after tax impact of the following items from net income (loss): (a) net income attributable to noncontrolling interests; (b) acquisition and integration expenses; (c) loss (income) from discontinued operations; (d) minority interest from discontinued operations; (e) loss (gain) on disposition of businesses/assets; (f) loss on early extinguishment of debt; (g) expenses associated with merger, net of tax; (h) certain legal settlements and related expenses; (i) amortization of pension and postretirement actuarial losses (gains); and (j) restructuring, impairment and plant closing and transition costs (credits). The income tax impacts, if any, of each adjusting item represent a ratable allocation of the total difference between the unadjusted tax expense and the total adjusted tax expense, computed without consideration of any adjusting items using a with and without approach. We do not adjust for changes in tax valuation allowances because we do not believe it provides more meaningful information than is provided under GAAP. The reconciliation of adjusted net income (loss) to net income (loss) is set forth in these tables. Pro forma adjusted to exclude the sale of our European differentiated surfactants business to Innospec Inc. on December 30, 2016 as if it had occurred at the beginning of the relevant period. Management internally uses a free cash flow measure: (a) to evaluate the Company's liquidity, (b) to evaluate strategic investments, (c) to plan stock buyback and dividend levels and (d) to evaluate the Company's ability to incur and service debt. Free cash flow is not a defined term under U.S. GAAP, and it should not be inferred that the entire free cash flow amount is available for discretionary expenditures. The Company defines free cash flow as cash flow provided by operating activities less cash flow used in investing activities, excluding acquisition/disposition activities and non-recurring separation costs. Free cash flow is typically derived directly from the Company's condensed consolidated statement of cash flows; however, it may be adjusted for items that affect comparability between periods. During the third quarter of 2017 we separated our Pigments and Additives division through an Initial Public Offering of Venator Materials PLC; Additionally, during the first quarter 2010 we closed our Australian styrenics operations. Results from these associated businesses are treated as discontinued operations. 1) 2) 3) 4) 20 |
